On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

Investing.com -- Merck &Company Inc (NYSE:MRK) shares tumbled more than 10% Tuesday after reporting mixed fourth-quarter results, with earnings falling short of expectations, revenue surpassing estima ...

Courtney Breen, senior analyst of U.S. biopharmaceuticals at Bernstein, discusses Merck's slump in the market following its halt of Gardasil and HPV vaccine shipments in China. February 04, 2025 at ...

Shares in Merck – known outside North America as MSD – tumbled after the drugmaker said it was halting shipments of a top-selling vaccine to China to help a key local supplier reduce excess ...

Merck (NSE:PROR) posted adjusted earnings per share (EPS) of $1.72 for Q4, missing the analyst consensus of $1.81 by $0.09. However, revenue for the quarter came in at $15.6 billion, beating the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Merck shares tumbled after the drugmaker said it was halting shipments of a top-selling vaccine to China to ...

Sustainability and climate change should be included in the way chemistry is taught - so we brought key stakeholders to discuss what the best way to do that looks like. Dr Siân Fussell, Dr Layla ...

The Queen also holds a number of patronages, including the Royal Literary Fund, the Royal Academy of Dance, the Royal Voluntary Service and the Army Benevolent Fund, and undertakes her own public ...

The most recent trading session ended with Merck (MRK) standing at $97.45, reflecting a -0.5% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...